Synairgen plc Holding(s) in Company (3364F)
November 13 2020 - 11:03AM
UK Regulatory
TIDMSNG
RNS Number : 3364F
Synairgen plc
13 November 2020
Synairgen plc
("Synairgen" or the "Company")
Holding(s) in Company
Southampton, UK , : Synairgen plc (LSE: SNG), the respiratory
drug discovery and development company, announces that it was
informed on 13 November 2020 that Leonard Licht, a private
investor, now holds less than 3% of the Company's issued share
capital.
Enquiries:
Synairgen plc +44 (0) 23 8051 2800
Richard Marsden (Chief Executive Officer)
John Ward (Finance Director)
finnCap - Nominated Adviser and Joint Broker +44 (0) 20 7220
0500
Geoff Nash / Kate Bannatyne / Charlie Beeson (Corporate
Finance)
Alice Lane / Sunila de Silva (ECM)
Numis - Joint Broker +44 (0) 20 7260 1000
James Black / Freddie Barnfield / Duncan Monteith
Consilium Strategic Communications - Financial Media and
Investor +44 (0) 20 3709 5700
Relations Adviser
Mary-Jane Elliott / Sue Stuart / Olivia Manser
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLFLFIDLFLVLII
(END) Dow Jones Newswires
November 13, 2020 12:03 ET (17:03 GMT)
Synairgen (LSE:SNG)
Historical Stock Chart
From Apr 2024 to May 2024
Synairgen (LSE:SNG)
Historical Stock Chart
From May 2023 to May 2024